ISpecimen Gross Profit 2020-2025 | ISPC
ISpecimen gross profit from 2020 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| ISpecimen Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $4 |
| 2023 | $5 |
| 2022 | $6 |
| 2021 | $6 |
| 2020 | $5 |
| 2019 | $2 |
| ISpecimen Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $1 |
| 2024-06-30 | $1 |
| 2024-03-31 | $1 |
| 2023-12-31 | $1 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $2 |
| 2022-12-31 | $2 |
| 2022-09-30 | $1 |
| 2022-06-30 | $1 |
| 2022-03-31 | $1 |
| 2021-12-31 | $1 |
| 2021-09-30 | $2 |
| 2021-06-30 | $1 |
| 2021-03-31 | $1 |
| 2020-12-31 | |
| 2020-09-30 | $1 |
| 2020-06-30 | $1 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.003B | $0.009B |
| iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.561B | 26.74 |
| Elevance Health (ELV) | United States | $88.026B | 11.36 |
| CVS Health (CVS) | United States | $80.784B | 10.04 |
| Cencora (COR) | United States | $55.036B | 19.15 |
| DiDi Global (DIDIY) | China | $23.580B | 35.79 |
| Natera (NTRA) | United States | $22.420B | 0.00 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.007B | 0.00 |
| Solventum (SOLV) | United States | $12.962B | 13.72 |
| CochLear (CHEOY) | Australia | $11.342B | 0.00 |
| ICON (ICLR) | Ireland | $11.283B | 10.49 |
| Revvity (RVTY) | United States | $10.948B | 18.84 |
| Doximity (DOCS) | United States | $10.905B | 50.49 |
| Viatris (VTRS) | United States | $10.340B | 3.55 |
| HealthEquity (HQY) | United States | $9.613B | 42.11 |
| Avantor (AVTR) | United States | $9.165B | 13.32 |
| Medpace Holdings (MEDP) | United States | $8.574B | 22.77 |
| Sonic Healthcare (SKHHY) | Australia | $8.388B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.243B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.238B | 24.96 |
| BrightSpring Health Services (BTSG) | United States | $4.157B | 38.48 |
| Sotera Health (SHC) | United States | $3.508B | 19.93 |
| Surgery Partners (SGRY) | United States | $2.994B | 38.93 |
| Alignment Healthcare (ALHC) | United States | $2.924B | 0.00 |
| Concentras Parent (CON) | United States | $2.830B | 16.36 |
| Organon (OGN) | United States | $2.537B | 2.70 |
| GeneDx Holdings (WGS) | United States | $2.066B | 79.58 |
| Ardent Health Partners (ARDT) | United States | $1.957B | 8.34 |
| Premier (PINC) | United States | $1.900B | 14.43 |
| Progyny (PGNY) | United States | $1.883B | 41.45 |
| PACS (PACS) | United States | $1.586B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.468B | 29.36 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.214B | 9.24 |
| Establishment Labs Holdings (ESTA) | $1.113B | 0.00 | |
| CareDx (CDNA) | United States | $1.098B | 17.15 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.944B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.818B | 7.66 |
| QDM (QDMI) | Hong Kong, SAR China | $0.752B | 0.00 |
| Nutex Health (NUTX) | United States | $0.654B | 9.90 |
| Embecta (EMBC) | United States | $0.579B | 3.90 |
| LifeMD (LFMD) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.546B | 44.92 |
| InnovAge Holding (INNV) | United States | $0.520B | 0.00 |
| SBC Medicals (SBC) | United States | $0.507B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.437B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.244B | 0.00 |
| Oncology Institute (TOI) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.099B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.081B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |